Only Cx43/hsa_circ_0077755/miR-182 axis, specific to Cx43 loss, was validated (Fig. 1), might serve as a biomarker signature axis for heightened-risk of breast cancer initiation and its dysregulation patterns seem to predict prognosis along breast cancer initiation and progression. This evidence concerns the gene GJA1 and breast carcinoma.